Goodman, Aaron
Patel, Sandip P.
Kurzrock, Razelle
Article History
First Online: 2 November 2016
Competing interests
: A.G. has received fellowship funding from Pfizer. S.P.P. has received research funding from Amgen, MedImmune, Pfizer, and Xcovery; consulting fees from Lilly; and speaking fees from Boehringer Ingelheim. R.K. has received research funds from Foundation Medicine, Genentech, Guardant, Merck Serono, Pfizer, and Sequenom; consultant fees from Sequenom; and has an ownership interest in CureMatch and Novena.